SAN JUAN CAPISTRANO, Calif., Oct. 05, 2016 -- Capitalizing on its recent streak of garnering exclusive product representation, SM Ingredients (SMI), a premier distributor and marketer to the food, nutrition, animal, and beverage industries, today announced the appointment of Lara Bova to its corporate sales and marketing team. The 12-year industry veteran was recruited specifically for her expertise and knowledge of nutritional supplements.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/2f543bd7-0258-4ecf-a958-96b881ad04d3
“Once again, we’re bridging the gap between manufacturer, distributor, and eventual end-users,” exclaimed Steve Marantette, SMI CEO and founder. “Lara is the quintessential hire because of her diversified background in quality assurance, purchasing, and sales. She will bring a distinctive skill set to our customer base and future prospects.”
A 2008 graduate of the University of Phoenix, where she earned a Bachelor’s of Science in Business Management, Bova’s professional experience includes terms at MeriCal and Barrington Nutritionals.
“My years of experience, particularly the manufacturing knowledge I gained while at MeriCal, has prepared me for this extraordinary opportunity at SMI,” Bova said. “Moreover, all customers ultimately count on expert assistance, advanced product knowledge, and value-added price points, so it’s my pledge to deliver superior account management that the marketplace has come to expect.”
Residing in the Temecula Valley, CA, Bova and her husband enjoy their time together with friends, family, and especially their toddler daughter. In her spare time away from the office, she also participates in CrossFit and extreme events such as Tough Mudder and Spartan Races.
“Lara’s mission is to support the growth and success of our clients,” Marantette concluded. “What more could we ask of a valued colleague? She is a well-liked sales executive that has dedicated herself to offer advanced technical support, exceptional customer service, and, the SMI x-factor, tangible integrity.”
ABOUT SM INGREDIENTS
SM Ingredients is a premier distributor/supplier within the food, nutrition, animal, and beverage industries. The company’s foundation is built on the principle of integrity, which is why it provides and promotes transparency throughout its supply chain. SMI’s diverse portfolio of ingredients includes prebiotic fiber based products; sweeteners; cellulose ethers; and various specialty ingredients. SMI prides itself upon strong relationships with manufacturers/suppliers, allowing the company to provide reliable, high quality ingredients at competitive price points. For more information, visit www.smingredients.com.
SMI Contact: Jerome Schulte [email protected] 949.388.0317 Agency Contact: Marty Vasquez [email protected] 714.917.5140


GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Italy Fines Apple €98.6 Million Over App Store Dominance
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



